Community Contributor
Member since 2025
Views
7.6k Total number of views
Fair Values Set
129 Total number of fair values set
Comments
0 Total number of comments
Followers
1 Total number of followers

Stock Research Today, provides investors with real-time market analysis, expert research, and curated financial content to support smarter, data-driven investment decisions.

No link added
RNXT logo
RenovoRx

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.Read more

View narrative
US$4.2
80.5% undervalued intrinsic discount
Fair Value
Profit Margin
36%
Future PE
15x
Price in 2029
US$10.53